Trevena Inc (TRVN)

Trevena Inc (TRVN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $57,010; returns 1 day +0.0%.

Trevena Inc. is a biopharmaceutical company specializing in the discovery and development of novel medicines for central nervous system (CNS) disorders, leveraging its proprietary G protein-coupled receptor (GPCR) biased ligand technology. Historically, the company commercialized OLINVYK (oliceridine) injection for moderate-to-severe acute pain in adults.

Groups TRVN belongs to

• Biopharmaceutical
• Healthcare
• Biotechnology
• CNS Disorders
• GPCR Targeting
• Pain Management
• Clinical Stage Biopharma
• Drug Discovery
• Strategic Pivot
• Neuroscience

TRVN financial model: income statement, cash flow and balance sheet